Given that TAOK2 is a validated risk gene for autism,5 schizophrenia,3 and Alzheimer disease,8,9 pharmacological targeting of TAOK2 or its downstream pathways may offer a promising therapeutic avenue for these neurodevelopmental and neuropsychiatric disorders. This evidence concerns the gene TAOK2 and schizophrenia.